{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:20:25Z","timestamp":1788942025528,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["NHMRC - APP1048740"],"award-info":[{"award-number":["NHMRC - APP1048740"]}]},{"name":"NHMRC Senior Research Fellowship","award":["APP1061332"],"award-info":[{"award-number":["APP1061332"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>Up to 10% of cystic fibrosis (CF) children develop cirrhosis by the first decade. We evaluated the utility of two simple biomarkers, aspartate aminotransferase to platelet ratio index (APRI) and FIB\u20104, in predicting degree of fibrosis in pediatric CF liver disease (CFLD) validated by liver biopsy. In this retrospective, cross\u2010sectional study, 67 children with CFLD had dual\u2010pass liver biopsies and 104 age\u2010 and sex\u2010matched CF children without liver disease (CFnoLD) had serum to calculate APRI and FIB\u20104 collected at enrollment. CFLD was defined as having two of the following: (1) hepatomegaly \u00b1 splenomegaly; (2) &gt;6 months elevation of ALT (&gt;1.5\u00d7 upper limit of normal ULN); or (3) abnormal liver ultrasound findings. Biopsies were staged according to Metavir classification by two blinded pathologists. Receiver operating characteristic (ROC) analysis and continuation ratio logistic regression were performed to assess the predictability of these biomarkers to distinguish CFLD from CFnoLD and determine fibrosis stage\u2010specific cut\u2010off values. The AUC for APRI was better than FIB\u20104 (0.75 vs. 0.60; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) for predicting CFLD and severe CFLD (F3\u2010F4) (0.81). An APRI score &gt;0.264 demonstrated a sensitivity (95% confidence interval [CI]) of 73.1% (60.9, 83.2) and specificity of 70.2% (60.4, 78.8) in predicting CFLD. A 50% increase in APRI was associated with a 2.4\u2010fold (95% CI: 1.7, 3.3) increased odds of having CFLD. APRI demonstrated full agreement with histology staging 37% of the time, but was within one stage 73% of the time. Only FIB\u20104 predicted portal hypertension at diagnosis (area under the receiver operator characteristic curve [AUC] = 0.91; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> This is the first liver biopsy\u2010validated study of APRI and FIB\u20104 in pediatric CFLD. APRI appears superior to FIB\u20104 in differentiating CFLD versus CFnoLD. APRI also exhibited a high AUC in predicting severe liver fibrosis with specific cutoffs for lower stages. (H<jats:sc>epatology<\/jats:sc> 2015;62:1576\u20131583)<\/jats:p>","DOI":"10.1002\/hep.28016","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:08:53Z","timestamp":1438218533000},"page":"1576-1583","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":103,"title":["Aspartate aminotransferase to platelet ratio and fibrosis\u20104 as biomarkers in biopsy\u2010validated pediatric cystic fibrosis liver disease"],"prefix":"10.1097","volume":"62","author":[{"given":"Daniel H.","family":"Leung","sequence":"first","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology, Nutrition,Baylor College of Medicine,Houston,TX"},{"name":"Texas Children's Liver Center,Houston,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahjabeen","family":"Khan","sequence":"additional","affiliation":[{"name":"Texas Children's Liver Center,Houston,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Minard","sequence":"additional","affiliation":[{"name":"Dan L. Duncan Institute for Clinical and Translational Research,Baylor College of Medicine,Houston,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Guffey","sequence":"additional","affiliation":[{"name":"Dan L. Duncan Institute for Clinical and Translational Research,Baylor College of Medicine,Houston,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Ramm","sequence":"additional","affiliation":[{"name":"Hepatic Fibrosis Group,QIMR Berghofer Medical Research Institute,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Clouston","sequence":"additional","affiliation":[{"name":"Envoi Pathology and University of Queensland,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Miller","sequence":"additional","affiliation":[{"name":"Envoi Pathology and University of Queensland,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lewindon","sequence":"additional","affiliation":[{"name":"Hepatic Fibrosis Group,QIMR Berghofer Medical Research Institute,Brisbane,QLD,Australia"},{"name":"Department of Gastroenterology,Royal Children's Hospital,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross W.","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology, Nutrition,Baylor College of Medicine,Houston,TX"},{"name":"Texas Children's Liver Center,Houston,TX"},{"name":"Hepatic Fibrosis Group,QIMR Berghofer Medical Research Institute,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[{"name":"Hepatic Fibrosis Group,QIMR Berghofer Medical Research Institute,Brisbane,QLD,Australia"},{"name":"Faculty of Medicine and Biomedical Sciences,The University of Queensland,Brisbane,QLD,Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"hep28016-bib-0001-20241017","first-page":"e11215","article-title":"Liver disease in cystic fibrosis: an update","volume":"13","year":"2013","journal-title":"Hepat Mon"},{"key":"hep28016-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep28016-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.24212","article-title":"Cystic fibrosis\u2010cirrhosis, portal hypertension, and liver biopsy: reply","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep28016-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/PAP.0b013e31825c6a20","article-title":"Liver biopsy in modern clinical practice: a pediatric point\u2010of\u2010view","volume":"19","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"hep28016-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep.24014","article-title":"Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep28016-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.2006.115410","article-title":"The incidence and risks of liver biopsy in non\u2010cirrhotic patients: An evaluation of 3806 biopsies","volume":"56","year":"2007","journal-title":"Gut"},{"key":"hep28016-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/jhep.2001.0103303le01","article-title":"The risks of percutaneous liver biopsy","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep28016-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MPG.0b013e318249c12a","article-title":"Evaluation of risk factors for bleeding after liver biopsy in children","volume":"55","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1319-3767.91735","article-title":"Outpatient blind percutaneous liver biopsy in infants and children: is it safe?","volume":"18","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"hep28016-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/BF02079063","article-title":"Complications of percutaneous liver biopsy in infants and children","volume":"154","year":"1995","journal-title":"Eur J Pediatr"},{"key":"hep28016-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2007.11.053","article-title":"Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"hep28016-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1002\/hep.21046","article-title":"Noninvasive measures of liver fibrosis","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep28016-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep28016-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-230X-12-14","article-title":"Diagnostic accuracy of the aspartate aminotransferase\u2010to\u2010platelet ratio index for the prediction of hepatitis B\u2010related fibrosis: a leading meta\u2010analysis","volume":"12","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"hep28016-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase\u2010to\u2010platelet ratio index for the staging of hepatitis C\u2010related fibrosis: an updated meta\u2010analysis","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep28016-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPG.0b013e3181aed725","article-title":"Performance of the AST\u2010to\u2010platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis","volume":"50","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpedsurg.2012.10.010","article-title":"Aspartate aminotransferase\u2010to\u2010platelet ratio index (APRI) in infants with biliary atresia: prognostic value at presentation","volume":"48","year":"2013","journal-title":"J Pediatr Surg"},{"key":"hep28016-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MPG.0b013e3181da1d98","article-title":"Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase\u2010to\u2010platelet ratio index in children with biliary atresia","volume":"51","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep28016-bib-0020-20241017","first-page":"260","article-title":"[Presentation of a grid for computer analysis for compilation of histopathologic lesions in chronic viral hepatitis C. Cooperative study of the METAVIR group]. [Article in French]","volume":"13","year":"1993","journal-title":"Ann Pathol"},{"key":"hep28016-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2004.06.032","article-title":"Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease","volume":"41","year":"2004","journal-title":"J Hepatol"},{"key":"hep28016-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MPG.0000000000000600","article-title":"Circulating MicroRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis","volume":"60","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0b013e31812e56ff","article-title":"Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy","volume":"45","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jcf.2011.04.004","article-title":"Transient elastography and portal hypertension in pediatric patients with cystic fibrosis transient elastography and cystic fibrosis","volume":"10","year":"2011","journal-title":"J Cyst Fibros"},{"key":"hep28016-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00247-009-1531-z","article-title":"Transient elastography in patients with cystic fibrosis","volume":"40","year":"2010","journal-title":"Pediatr Radiol"},{"key":"hep28016-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcf.2009.08.001","article-title":"Non\u2010invasive liver elastography (Fibroscan) for detection of cystic fibrosis\u2010associated liver disease","volume":"8","year":"2009","journal-title":"J Cyst Fibros"},{"key":"hep28016-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcf.2007.08.001","article-title":"Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease","volume":"7","year":"2008","journal-title":"J Cyst Fibros"},{"key":"hep28016-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvh.12224","article-title":"The validity of serum markers for fibrosis staging in chronic hepatitis B and C","volume":"21","year":"2014","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"hep28016-bib-0029-20241017","first-page":"S1","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep28016-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/liv.12113","article-title":"Utility of transient elastography in the non\u2010invasive evaluation of cystic fibrosis liver disease","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"hep28016-bib-0031-20241017","first-page":"1005","article-title":"[Value of transient elastography in noninvasive assessment in children's hepatic fibrosis]. [Article in French]","volume":"16","year":"2009","journal-title":"Arch Pediatr"},{"key":"hep28016-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"e42139","DOI":"10.1371\/journal.pone.0042139","article-title":"Non\u2010invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores","volume":"7","year":"2012","journal-title":"PLoS One"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28016","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201511000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:28:37Z","timestamp":1729211317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201511000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28016","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]},"assertion":[{"value":"2015-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}